Literature DB >> 18609153

Terlipressin-induced ventricular arrhythmia.

Ján Urge1, Frantisek Sincl, Vlastimil Procházka, Karel Urbánek.   

Abstract

During intravenous treatment with terlipressin for recurrent gastrointestinal (GI) bleeding, a 50-year-old male with no history of heart disease developed a newly prolonged QT interval and torsade de pointes. Risk factors present for acquired long QT syndrome were mineral dysbalance and a history of alcohol abuse with hepatic impairment. The patient was brought back to a normal sinus rhythm after a single 300-J counter-shock. Terlipressin was discontinued, and the patient's QTc interval subsequently returned to baseline. During 6 weeks of monitoring, arrhythmia did not recur.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18609153     DOI: 10.1080/00365520801905304

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  [54-year-old male with hepatic cirrhosis and therapy-associated torsade de pointes tachycardia].

Authors:  M Lehmann; T Bruns; A Herrmann; M Fritzenwanger; A Stallmach
Journal:  Internist (Berl)       Date:  2011-04       Impact factor: 0.743

Review 2.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

3.  Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.

Authors:  Toonchai Indrambarya; John H Boyd; Yingjin Wang; Melissa McConechy; Keith R Walley
Journal:  Crit Care       Date:  2009-06-23       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.